VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
L
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LLoews Corporation
$109.71$22.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLFinancials

Loews Corporation (L) Income Statement

30Y historyFree accessUpdated daily

Revenue grew to $4.8B in Q3 2026 with a 56.4% loss ratio and 89.3% combined ratio, suggesting underwriting profitability that remains sensitive to quarterly reserve development.

Income StatementBalance SheetCash FlowRatios

L Income Statement

Annual statement

L Income Statement

Loews Corporation (L) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue18.71B18.18B17.24B15.68B14.05B13.73B13.67B14.73B14.04B13.73B13.11B13.41B14.32B14.61B14.07B14.13B14.62B14.12B13.25B14.3B17.91B16.02B15.24B16.29B17.46B18.74B20.63B21.47B21.3B20.14B20.44B
Revenue Growth %4.03%5.44%9.96%11.59%2.35%0.44%-7.2%4.86%2.25%4.81%-2.31%-6.35%-1.97%3.84%-0.4%-3.33%3.53%6.57%-7.38%-20.15%11.82%5.09%-6.45%-6.7%-6.79%-9.19%-3.88%0.79%5.75%-1.49%9.45%
Medical Costs & Claims10.01B10.19B9.54B8.71B8.14B7.81B7.58B7.19B6.91B6.54B6.52B6.92B6.91B7.17B7B6.67B6.15B6.71B07.53B7.58B8.54B8.13B11.88B10.18B13.19B11.71B14.03B14.03B13.41B13.56B
Medical Cost Ratio %53.51%56.07%55.32%55.57%57.96%56.92%55.46%48.82%49.18%47.64%49.74%51.61%48.22%49.05%49.77%47.17%42.1%47.51%0%52.64%42.32%53.32%53.31%72.92%58.3%70.38%56.76%65.38%65.87%66.57%66.35%
Gross Profit8.7B7.98B7.7B6.97B5.91B5.91B6.09B7.54B7.14B7.19B6.59B6.49B7.42B7.45B7.07B7.46B8.46B7.41B13.25B6.77B10.33B7.48B7.12B4.41B7.28B5.55B8.92B7.43B7.27B6.73B6.88B
Gross Margin %46.49%43.93%44.68%44.43%42.04%43.08%44.54%51.18%50.82%52.36%50.26%48.39%51.78%50.95%50.23%52.83%57.9%52.49%100%47.36%57.68%46.68%46.69%27.08%41.7%29.62%43.24%34.62%34.13%33.43%33.65%
Gross Profit Growth %-3.65%10.58%17.93%-0.1%-2.86%-19.25%5.62%-0.76%9.18%1.48%-12.48%-0.38%5.32%-5.29%-11.79%14.2%-44.06%95.59%-34.44%38.17%5.05%61.28%-39.4%31.21%-37.8%20.04%2.25%7.97%-2.15%-0.03%
Operating Expenses5.8B5.7B5.83B4.97B4.79B3.75B7.55B6.42B6.3B5.61B5.65B6.25B5.61B5.17B5.05B5.24B5.56B5.68B13.25B3.58B5.86B5.63B5.29B5.79B5.62B6.31B5.79B6.49B6.19B5.14B4.47B
OpEx / Revenue %31.02%31.37%33.81%31.7%34.11%27.34%55.25%43.59%44.88%40.84%43.12%46.57%39.14%35.37%35.87%37.07%38.04%40.24%100%25.02%32.71%35.15%34.74%35.52%32.16%33.7%28.04%30.23%29.07%25.52%21.88%
Depreciation & Amortization139M610M583M538M509M515M734M943M912M874M841M955M899M871M905M833M816M784M692M205M-8M174.5M329.3M192M139M58.7M-13.9M395.3M437M341.7M285M
Combined Ratio %84.53%87.44%89.13%87.27%92.07%84.26%110.71%92.4%94.06%88.48%92.86%98.18%87.36%84.42%85.63%84.25%80.14%87.75%100%77.66%75.03%88.47%88.05%108.44%90.46%104.08%84.8%95.6%94.94%92.09%88.22%
Operating Income2.9B2.28B1.87B2B1.11B2.16B-1.46B1.12B834M1.58B936M244M1.81B2.28B2.02B2.23B2.9B1.73B03.19B4.47B1.85B1.82B-1.38B1.67B-764.5M3.14B944.2M1.08B1.59B2.41B
Operating Margin %15.47%12.56%10.87%12.73%7.93%15.74%-10.71%7.6%5.94%11.52%7.14%1.82%12.64%15.58%14.37%15.75%19.86%12.25%0%22.34%24.97%11.53%11.95%-8.44%9.54%-4.08%15.2%4.4%5.06%7.91%11.78%
Operating Income Growth %-21.82%-6.11%79.17%-48.43%247.54%-230.83%34.17%-47.28%69.02%283.61%-86.52%-20.51%12.61%-9.16%-23.29%67.75%--100%-28.56%142.19%1.34%232.51%-182.53%317.93%-124.38%232.12%-12.36%-32.38%-33.83%-15.2%
EBITDA3.15B2.89B2.46B2.53B1.62B2.67B-730M2.06B1.75B2.46B1.78B1.2B2.71B3.15B2.93B3.06B3.72B2.51B1.62B3.4B4.46B2.02B2.15B-1.18B1.81B-705.8M3.12B1.34B1.51B1.93B2.69B
EBITDA Margin %16.82%15.92%14.25%16.16%11.55%19.49%-5.34%14%12.43%17.88%13.56%8.94%18.91%21.54%20.8%21.65%25.44%17.81%12.26%23.77%24.92%12.62%14.11%-7.26%10.34%-3.77%15.13%6.24%7.11%9.61%13.17%
Interest Expense430M437M441M376M378M424M515M591M574M646M536M520M498M425M426M522M517M448M345M318M304.1M364.2M324.1M308.4M309.6M332M356.9M354.3M369.2M323.4M318M
Non-Operating Income-113M-437M-441M-376M-378M-424M-515M-591M-574M-646M-536M-520M-498M-425M-426M-522M-517M-448M-932M-318M-304.1M-364.2M-324.1M-305M-309.6M-332M-356.9M-354.3M-369.2M-323.4M-318M
Pretax Income2.02B2.28B1.87B2B1.11B2.16B-1.46B1.12B834M1.58B936M244M1.81B2.28B2.02B2.23B2.9B1.73B587M3.19B4.47B1.85B1.82B-1.38B1.67B-764.5M3.14B944.2M1.08B1.59B2.41B
Pretax Margin %10.81%12.56%10.87%12.73%7.93%15.74%-10.71%7.6%5.94%11.52%7.14%1.82%12.64%15.58%14.37%15.75%19.86%12.25%4.43%22.34%24.97%11.53%11.95%-8.44%9.54%-4.08%15.2%4.4%5.06%7.91%11.78%
Income Tax229M511M380M451M223M475M-173M248M128M170M220M-43M457M656M513M532M894M345M7M995M1.45B490.4M533.8M-534.1M579.8M-178.4M1.09B-305.5M-354.5M-495.3M-791.4M
Effective Tax Rate %11.33%22.38%20.28%22.6%20.02%21.99%11.82%22.16%15.35%10.75%23.5%-17.62%25.25%28.81%25.37%23.9%30.81%19.94%1.19%31.14%32.44%26.56%29.3%38.84%34.8%23.34%34.75%-32.36%-32.9%-31.09%-32.87%
Net Income1.74B1.67B1.41B1.43B822M1.56B-931M932M636M1.16B654M260M591M595M568M1.06B1.29B564M4.53B2.49B2.49B1.21B1.23B-597M912M-553.8M1.85B363.2M464.8M793.6M1.38B
Net Margin %9.3%9.17%8.2%9.15%5.85%11.38%-6.81%6.33%4.53%8.47%4.99%1.94%4.13%4.07%4.04%7.52%8.82%4%34.2%17.4%13.91%7.56%8.08%-3.66%5.22%-2.96%8.96%1.69%2.18%3.94%6.77%
Net Income Growth %19.83%17.89%-1.39%74.45%-47.38%267.78%-199.89%46.54%-45.36%77.98%151.54%-56.01%-0.67%4.75%-46.52%-17.61%128.55%-87.55%82%-0.09%105.62%-1.6%306.25%-165.46%264.68%-129.96%408.98%-21.86%-41.43%-42.65%-21.62%
EPS (Diluted)8.517.976.416.293.386.00-3.323.071.993.451.930.721.551.531.432.633.071.309.053.653.751.721.88-1.281.64-0.943.100.560.681.151.99
EPS Growth %4.49%24.34%1.91%86.09%-43.67%280.72%-208.14%54.27%-42.32%78.76%168.06%-53.55%1.31%6.99%-45.63%-14.33%136.15%-85.64%147.95%-2.67%118.02%-8.51%246.88%-178.05%274.47%-130.32%453.57%-17.65%-40.87%-42.21%-20.4%
EPS (Basic)-7.976.426.303.396.02-3.323.081.993.461.930.761.581.531.442.693.081.309.053.663.751.721.88-1.281.64-0.963.100.560.681.151.99
Diluted Shares Outstanding204.57M209.1M220.53M227.81M243.28M260.2M280.32M303.35M319.93M337.5M338.31M362.69M382.55M389.51M395.87M405.32M419.52M433.45M477.23M644.57M647.01M557.97M556.5M556.35M564.93M587.07M591.69M666.67M689.45M690.09M699.12M

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Social inflation casualty reserve pressure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Steady at Mid-Single Digits

Based on reported quarterly figures, Loews' revenue climbed from $4.2B in Q2 2024 to $4.8B in Q3 2026, with the latest quarter showing 3.4% year-over-year growth that suggests moderating expansion relative to the 12.9% peak in Q3 2024.

The revenue trajectory appears to reflect disciplined CNA premium growth and steady pipeline contributions rather than a step change in volume. The deceleration from double-digit growth in late 2024 may indicate a softening pricing tailwind or a more selective underwriting posture, which investors should monitor against the rate environment. Sustained mid-single-digit growth would be consistent with a mature insurance-led conglomerate rather than a business in an accelerating phase.

Underwriting Results Volatile Within Profitable Range

According to the reported quarterly income statements, Loews' combined ratio ranged from 72.4% in Q2 2026 to 95.8% in Q4 2024, with the most recent quarter at 89.3%, indicating underwriting profitability in most periods but meaningful quarterly dispersion.

Combined ratios below 100% indicate that CNA's underwriting operations generated profit before investment income, a favorable position that appears to have held across the ten-quarter window. The 95.8% reading in Q4 2024 and the spread between the best and worst quarters suggest sensitivity to catastrophe losses or reserve adjustments that the consolidated figures alone cannot fully isolate. Loss ratios near 47% to 57% imply that claims cost discipline is the primary driver of these results.

Reserve Development Warrants Closer Scrutiny

Reported loss ratios fluctuating between 47.7% and 57.1% across recent quarters may reflect reserve development effects that are not separately disclosed in the supplied income statement data, creating uncertainty about underlying loss trends.

The quarter-to-quarter swing in loss ratio, including the 47.7% reading in Q1 2026 against 56.3% in adjacent periods, could be consistent with favorable prior-year reserve releases flattering a given quarter. Given social inflation pressures in US casualty lines, investors should examine whether reserve strengthening is occurring in a manner that could reverse. Without explicit development tables in the supplied data, this assessment remains an inference warranting further investigation of the underlying filings.

Investment Income Contribution Not Separately Visible

Investment income and investment yield data are unavailable in the supplied quarterly figures, so the contribution of the insurance float to total earnings cannot be quantified from the data provided.

Net income has varied materially, from $187M in Q4 2024 to $572M in Q1 2026, and that dispersion may partly reflect investment portfolio marks rather than operating performance. The absence of reported investment income figures limits confidence in separating underwriting results from portfolio returns. Analysts should reference the segment disclosures to determine how much of recent earnings depend on fixed-income yields versus realized and unrealized gains.

Q4 2024 Earnings Trough Versus Recovery

Based on reported figures, Loews' operating income fell to $188M in Q4 2024 from $550M in the prior quarter, with EPS declining 56.6% year-over-year, before recovering to $541M in Q4 2025 and sustaining higher levels.

The Q4 2024 trough coincided with a combined ratio of 95.8%, the weakest underwriting result in the period, which suggests a concentrated pressure event rather than a broad deterioration. The subsequent recovery to $541M and beyond implies that the underlying franchise absorbed the shock without lasting impairment. Investors should determine whether the Q4 2024 pressure reflected catastrophe activity or reserve charges, as the answer shapes how durable the recovery may be.

Reported Earnings May Overstate Underwriting Durability

As reported in the quarterly figures, Loews' Q1 2026 net income of $572M on a 47.7% loss ratio may reflect favorable reserve development or portfolio marks, and investors should test whether that level is repeatable against a 56% to 57% loss ratio run rate.

The strongest challenge to the reported earnings base is that the lowest loss ratio readings may be flattering the trend, and Q1 2026 EPS of $1.63 sits well above the $0.86 to $1.92 range seen in adjacent quarters. If social inflation is lifting casualty severity, a return toward the 56% to 57% loss ratio band would compress combined ratios back toward 88% to 89% and reduce earnings power. Without disclosed reserve development tables or investment income detail in the supplied data, this remains an analytical inference warranting further review of the underlying filings.

L — Frequently Asked Questions

Quick answers to the most common questions about buying L stock.

What was Loews Corporation's (L) revenue in 2025?

For fiscal year 2025, Loews Corporation (L) reported total revenue of $18.18B. This represents a 11.1% decline compared to $20.44B in 1996.

Is Loews Corporation (L) profitable?

Loews Corporation (L) is profitable, generating $1.67B in net income for the fiscal year ending 2025 with a net profit margin of 9.2%.

What is Loews Corporation's operating profit margin?

Loews Corporation (L) reported an operating income of $2.28B, resulting in an operating profit margin of 12.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Loews Corporation's gross profit and gross margin?

Loews Corporation (L) generated $7.98B in gross profit for the year, representing a gross profit margin of 43.9%. This demonstrates the company's core pricing power and production efficiency.